Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 High hematocrit as a risk factor for venous thrombosis. Cause or innocent bystander?

Literature DB >> 20139389

High hematocrit as a risk factor for venous thrombosis. Cause or innocent bystander?

Anja J M Schreijer, Pieter H Reitsma, Suzanne C Cannegieter.

Abstract

Entities: Disease

Mesh：

Year: 2010 PMID： 20139389 PMCID： PMC2817018 DOI： 10.3324/haematol.2009.017285

Source DB: PubMed Journal: Haematologica ISSN： 0390-6078 Impact factor: 9.941

× No keyword cloud information.

21 in total

1. Incidence of venous thromboembolism: a community-based study in Western France. EPI-GETBP Study Group. Groupe d'Etude de la Thrombose de Bretagne Occidentale.

Authors: E Oger
Journal: Thromb Haemost Date: 2000-05 Impact factor: 5.249

2. Daily aspirin--only half the answer.

Authors: Jerry Spivak
Journal: N Engl J Med Date: 2004-01-08 Impact factor: 91.245

3. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study.

Authors: F A Anderson; H B Wheeler; R J Goldberg; D W Hosmer; N A Patwardhan; B Jovanovic; A Forcier; J E Dalen
Journal: Arch Intern Med Date: 1991-05

4. Biological risk factors for deep vein trombosis.

Authors: Amparo Vayá; Yolanda Mira; Marcial Martínez; Piedad Villa; Fernando Ferrando; Amparo Estellés; Dolores Corella; Justo Aznar
Journal: Clin Hemorheol Microcirc Date: 2002 Impact factor: 2.375

5. Erythrocytes metabolically enhance collagen-induced platelet responsiveness via increased thromboxane production, adenosine diphosphate release, and recruitment.

Authors: J Valles; M T Santos; J Aznar; A J Marcus; V Martinez-Sales; M Portoles; M J Broekman; L B Safier
Journal: Blood Date: 1991-07-01 Impact factor: 22.113

6. Cardiovascular risk factors and venous thromboembolism incidence: the longitudinal investigation of thromboembolism etiology.

Authors: Albert W Tsai; Mary Cushman; Wayne D Rosamond; Susan R Heckbert; Joseph F Polak; Aaron R Folsom
Journal: Arch Intern Med Date: 2002-05-27

7. Vascular occlusive episodes and venous haematocrit in primary proliferative polycythaemia.

Authors: T C Pearson; G Wetherley-Mein
Journal: Lancet Date: 1978-12-09 Impact factor: 79.321

Review 8. The epidemiology of venous thromboembolism.

Authors: Richard H White
Journal: Circulation Date: 2003-06-17 Impact factor: 29.690

Review 9. Natural history of venous thromboembolism.

Authors: Clive Kearon
Journal: Circulation Date: 2003-06-17 Impact factor: 29.690

10. Enhancement of platelet reactivity and modulation of eicosanoid production by intact erythrocytes. A new approach to platelet activation and recruitment.

Authors: M T Santos; J Valles; A J Marcus; L B Safier; M J Broekman; N Islam; H L Ullman; A M Eiroa; J Aznar
Journal: J Clin Invest Date: 1991-02 Impact factor: 14.808

7 in total

High hematocrit as a risk factor for venous thrombosis. Cause or innocent bystander?

1. Incidence of venous thromboembolism: a community-based study in Western France. EPI-GETBP Study Group. Groupe d'Etude de la Thrombose de Bretagne Occidentale.

2. Daily aspirin--only half the answer.

3. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study.

4. Biological risk factors for deep vein trombosis.

5. Erythrocytes metabolically enhance collagen-induced platelet responsiveness via increased thromboxane production, adenosine diphosphate release, and recruitment.

6. Cardiovascular risk factors and venous thromboembolism incidence: the longitudinal investigation of thromboembolism etiology.

7. Vascular occlusive episodes and venous haematocrit in primary proliferative polycythaemia.

Review 8. The epidemiology of venous thromboembolism.

Review 9. Natural history of venous thromboembolism.

10. Enhancement of platelet reactivity and modulation of eicosanoid production by intact erythrocytes. A new approach to platelet activation and recruitment.

Review 1. Erythrocytosis Following Testosterone Therapy.

Review 2. Deep vein thrombosis: current status and nanotechnology advances.

3. Ischemic stroke as a presenting feature of VIPoma due to MEN 1 syndrome.

Review 4. Investigating the basis of sexual dysfunction during late-onset hypogonadism.

5. Effect of gender-affirming hormone use on coagulation profiles in transmen and transwomen.

6. A New Score for Determining Thrombus Burden in STEMI Patients: The MAPH Score.

7. Hematocrit and incidence of venous thromboembolism.